Furthermore, PPARγ can reduce PAH by decreasing inflammatory factor levels, inhibiting apoptosis and alleviating oxidative stress, and reducing vascular endothelial cell injury and vascular remodeling [29]. Here, PPARG is linked to pulmonary arterial hypertension.